Myo Jing Kim
Dong-a University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Myo Jing Kim.
Pediatrics International | 2013
Myo Jing Kim; Yu-Mi Kim; Jae-Ho Yoo
The aim of this study was to identify the status of exclusive breast‐feeding (EBF) in Korea and analyze the factors affecting exclusive breast‐feeding at 6 months of age.
Journal of Korean Medical Science | 2015
Jin A Lee; Myo Jing Kim; Sohee Oh; Byung Min Choi
This study aimed to investigate current therapeutic strategies for patent ductus arteriosus (PDA) in very-low-birth-weight (VLBW) infants in Korea. A total of 2,254 VLBW infants among 2,386 from Korean Neonatal Network cohort born from January 2013 to June 2014 were included. No PDA was seen for 1,206 infants (53.5%) and the infants diagnosed or treated for PDA were 1,048 infants (46.5%). The proportion of infants with PDA was decreased according to the increase in gestational age (GA) and birthweight. Infants with PDA were divided into groups according to the therapeutic strategies of PDA: prophylactic treatment (PT, n = 69, 3.1%), pre-symptomatic treatment (PST, n = 212, 9.4%), symptomatic treatment (ST, n = 596, 26.4%), and conservative treatment (CT, n = 171, 7.6%). ST was the most preferred treatment modality for preterm PDA and the proportion of the patients was decreased in the order of PST, CT, and PT. Although ST was still the most favored treatment in GA < 24 weeks group, CT was more preferred than PST or ST when compared with GA ≥ 32 weeks group [CT vs. PST, OR 5.3, 95% CI 1.56-18.18; CT vs. ST, OR 2.9, 95% CI 1.03-8.13]. A total of 877 infants (38.9%) received pharmacological or surgical treatment about PDA, and 35.5% (801 infants) received pharmacological treatment, mostly with ibuprofen. Seventy-six infants (3.4%) received primary ligation and 8.9% (201 infants) received secondary ligation. Diverse treatment strategies are currently used for preterm PDA in Korea. Further analyses of neonatal outcomes according to the treatment strategies are necessary to obtain a standardized treatment guideline for preterm PDA.
Annals of Pediatric Endocrinology & Metabolism | 2014
Myo Jing Kim; Young-Eun Kim; Jae Ho Yoo
Autosomal dominant neurohypophyseal diabetes insipidus is a rare form of central diabetes insipidus that is caused by mutations in the vasopressin-neurophysin II (AVP-NPII) gene. It is characterized by persistent polydipsia and polyuria induced by deficient or absent secretion of arginine vasopressin (AVP). Here we report a case of familial neurohypophyseal diabetes insipidus in four generations of a Korean family, caused by heterozygous missense mutation in exon 2 of the AVP-NPII gene (c.286G>T). This is the first report of such a case in Korea.
Paediatric and Perinatal Epidemiology | 2013
Jae Won Shim; Myo Jing Kim; Ee-Kyung Kim; Hyun Kyung Park; Eun Song Song; Soon Min Lee; Jang Hoon Lee; Hyun-Seung Jin; Eun Sun Kim; Yun Sil Chang
Korean Journal of Pediatrics | 2009
Myo Jing Kim
Korean Journal of Pediatrics | 2010
Soo Kyoung Park; Yu Jin Jung; Hye Soo Yoo; So Yoon Ahn; Hyun Joo Seo; Seo Heui Choi; Myo Jing Kim; Ga Won Jeon; Soo Hyun Koo; Kyung-Hoon Lee; Yun Sil Chang; Won Soon Park
Korean Journal of Pediatrics | 2008
Heewon Chueh; Myo Jing Kim; Jin A Jung
Korean Journal of Pediatrics | 2008
Heewon Chueh; Myo Jing Kim; Young-A Lee; Jin-A Jung
Journal of the Korean Society of Neonatology | 2011
Mi Jin Kim; Myung Chul Lee; Jae Ho Yoo; Myo Jing Kim
Neonatal medicine | 2011
Hye Soo Yoo; Myo Jing Kim; Ji Man Kang; Cha Gon Lee; Jin Kyu Kim; So Yoon Ahn; Eun Sun Kim; June Huh; Yun Sil Chang; I Seok Kang; Won Soon Park; Heung Jae Lee